Moneyboxx Q1FY27: PAT dips 15% YoY to ₹0.21 Cr as revenue falls 12%, credit costs ease
PAT -14.99% YoY · revenue -11.87% · margins compressing
₹52.02 Cr
-11.87% YoY
₹0.21 Cr
-14.99% YoY
0.4%
0pp YoY
₹0.03
Moneyboxx Finance's standalone Q1 FY27 (quarter ended June 30, 2026) PAT came in at ₹0.21 Cr, down 15% year-on-year from ₹0.24 Cr and down 56% sequentially from ₹0.47 Cr in Q4 FY26. Revenue from operations fell to ₹52.02 Cr, down 11.9% YoY and 17.6% QoQ, with the core interest income line down 10.5% YoY to ₹45.15 Cr. Net profit margin held roughly flat at ~0.40% of total income (vs 0.41% a year ago) but total expenses ate up 99.5% of income, leaving a razor-thin cushion consistent with the company's small scale. No street/analyst consensus estimates for this quarter could be found in a web search — Moneyboxx is a sub-₹300 Cr net-worth NBFC without visible brokerage coverage, so vsStreet is unknown. Management gave no separate press release or commentary beyond the board-meeting outcome letter and financial statements this quarter.
Q1 FY-2027 vs prior quarters
On management's own February 2026 concall guidance — AUM to cross ₹1,500 Cr by FY27 via a pivot to ~80% secured book by March 2027, credit costs normalizing below 2%, opex below 10% of average AUM within two years, and improving ROA/ROE from next fiscal — this quarter shows mixed but directionally consistent signals. The guided yield pressure from the secured shift appears to be playing out: interest income fell 10.5% YoY even as finance cost was nearly flat (+2.4% YoY to ₹21.10 Cr), pushing finance cost from 34.8% to 40.5% of total income — the squeeze is on the topline/yield side, not funding costs. Separately, impairment on financial instruments (credit cost) fell sharply to ₹2.19 Cr from ₹8.34 Cr a year ago and ₹12.04 Cr last quarter, a genuine positive that tracks toward the sub-2% credit-cost target, though the ratio can't be verified against average AUM since that figure wasn't disclosed. The core AUM growth target itself cannot be confirmed or denied from this filing.
The stock went into the print at ₹60, down 1.6% over the past month of trading.
Management guides for AUM to surpass INR 1,500 crores in FY27, driven by a strategic pivot to an approximately 80% secured portfolio by March '27. They anticipate credit costs will normalize below 2% and operating expenses will fall below 10% of average AUM within two years. While the secured shift pressures yields, th
Asset quality and capitalisation remain healthy: Gross Stage 3 assets ratio is 0.73% and Net Stage 3 is 0.36%, with capital-to-risk-weighted-assets at 28.65% and a debt-equity ratio of 2.20 against net worth of ₹296.48 Cr. The quarter's corporate actions reinforce the funding and growth story rather than the P&L: the Board approved an enabling authorization for up to ₹1,200 Cr of NCDs/commercial paper, on top of ₹50 Cr of NCDs already allotted to Capri Global and ₹500 million more raised in the quarter (₹700 million over four months). The company also crossed ₹10 Cr in solar loan disbursements — a new secured lending vertical that aligns with the guided secured-portfolio pivot — and opened a new branch in Tamil Nadu. The Board also reapproved Deepak Aggarwal as Co-CEO, CFO & Whole-time Director for a further five years from September 15, 2026, signalling management continuity through this transition phase. Net: this quarter reads as a soft print on revenue and profit, both YoY and sequentially, with the redeeming feature being sharply lower credit costs — the next 1-2 quarters need to show the AUM and secured-mix numbers actually materialising for the guidance to be validated.
W1
AUM trajectory toward management's >₹1,500 Cr FY27 target and secured-mix toward ~80% by March 2027 — this quarter's 10.5% YoY interest income decline is consistent with the pivot, but no AUM figure was disclosed to confirm progress
W2
Credit cost normalization below 2% (guided) — impairment provision fell to ₹2.19 Cr this quarter from ₹8.34 Cr YoY and ₹12.04 Cr QoQ; verify the trend holds against average AUM in coming quarters
W3
Utilization of the newly approved ₹1,200 Cr NCD/CP authorization and its effect on cost of funds — finance cost was ₹21.10 Cr this quarter (40.5% of total income), up from 34.8% a year ago
Statement is standalone only, no consolidated section. Figures in Rs. lakhs converted to Cr. No exceptional/one-off items flagged. Deferred tax expense (no current tax) both periods.
Informational and educational content only. Not investment advice.